Following a school-based measles-rubella vaccination campaign in November 1994, enhanced surveillance of measles, including IgM antibody testing of oral fluid from clinically diagnosed case-patients, was introduced in England and Wales. Between 1995 and 2001, 665 cases of measles were confirmed, including 371 (56%) confirmed only by IgM detection in oral fluid. Two hundred thirty-nine cases (36%) were sporadic and 426 (64%) were associated with 61 clusters. Fifty-four (23%) of the 239 sporadic cases and 26 (43%) of the 61 clusters were associated with a probable or possible importation of infection from overseas, and a wide variety of genotypes were identified in each calendar year. The effective reproduction number for measles over the period was estimated to be below 0.7. These data suggest that most measles in the United Kingdom is acquired following limited transmission from an imported infection, and they confirm that measles elimination has been achieved and sustained over this period.
In 1968, the United Kingdom introduced measles vaccine for children between the ages of 1 and 2 years, but throughout the 1970s and early 1980s, coverage remained below 80%. In 1988, the combined measlesmumps-rubella (MMR) vaccine was introduced in place of measles vaccine for children 13-15 months of age, and coverage improved to over 90%. Measles notifications declined to low levels, but in November 1994, all children aged 5-16 years in England and Wales were offered combined measles-rubella vaccine in an attempt to prevent a predicted epidemic [1] . This approach represented the first mass vaccination campaign in an industrialized country, although similar approaches had been widely used in Latin America [2, 3] . By the end of December 1994, 92% of school children had received measles-rubella vaccine [4] . The aim of the campaign was to hasten the elimination of measles. Elimination has been previously defined as "the reduction to zero of the incidence of a specified disease in a defined geographical area," but recent work suggests that the absence of sustained transmission may be a more realistic definition [5] .
Before the 1994 mass vaccination campaign, measles surveillance in England and Wales relied upon the notification of clinically diagnosed cases to the Office of National Statistics and upon reports of serologically confirmed cases by laboratories to the Public Health Laboratory Service (PHLS) Communicable Disease Surveillance Centre (CDSC). During 1991-1994, a study confirmed measles infection in ∼40% of clinically diagnosed notified cases by the detection of measles IgM in serum and demonstrated the sensitivity and specificity of an oral fluid assay [6] . After the vaccination campaign, surveillance was enhanced by followup all of notified cases with the offer of an IgM test on oral fluid [7] . Specimens from IgM-positive cases were also tested by reverse transcription-polymerase chain reaction (RT-PCR) for measles genome [8, 9] . This report summarizes the effect of the campaign on the epidemiology and origin of confirmed measles since 1995 and demonstrates the interruption of sustained indigenous transmission in the United Kingdom.
MATERIALS AND METHODS
Measles is a notifiable disease in England and Wales. Practitioners who diagnose measles are required by statute to report the case to the proper officer of the local authority (usually the Consultant in Communicable Disease Control [CCDC] ). Supplies of oral fluid testing kits have been distributed to the CCDC in all health authorities. When a case is notified, a kit is sent to the reporting doctor with a request for a sample of oral fluid. It is recommended that the sample be obtained within 6 weeks of onset by the practice nurse, doctor, parent, or patient and be posted in a reply-paid box to the PHLS Enteric, Respiratory and Neurological Virus Laboratory (ERNVL) [7] . Results are returned to the CCDC and general practitioner. For IgM-positive cases without a history of recent vaccination, a confirmatory serum sample is requested. For cases in preschool children with a low positive IgM (test/negative ratio of below 10.0), a second oral fluid sample is requested. Cases IgM positive by oral fluid testing but either IgM negative on serum sample testing or IgG and IgM negative on a second oral fluid sample are excluded, as are cases with a low positive IgM for whom further investigation is not conducted.
Confirmed measles infections are reported by laboratories in England and Wales (including ERNVL) to the CDSC, and the reported information includes the method of confirmation. For all reports of measles since 1995 from laboratories other than ERNVL, an aliquot of serum was requested for further testing at ERNVL. Cases that were IgM positive at the source laboratory but negative at ERNVL were tested by a third IgM assay and included if two assays were positive. Cases reported by laboratories with a high titer of measles IgG on a single serum specimen or by detection of measles antigen in a clinical specimen (such as nasopharyngeal aspirate) by immunofluorescence were excluded unless serum or oral fluid were also confirmed to be IgM positive [10] . The case definition is therefore a doctor-diagnosed case of measles that has been confirmed by the detection of measles IgM in oral fluid or serum or by the detection of a 4-fold rise in measles IgG in serum. Cases with a history of a measles-containing vaccine in the 6 weeks before onset are excluded.
For all confirmed cases, additional details, including vaccination status (if not supplied on the request form), contact history, and history of travel, are requested from the general practitioner. Missing vaccine histories for children !15 years of age are also checked on the computerized child health system for the health authority. If the practitioner and the child health system have no record of vaccination with measles, measlesrubella, or MMR vaccine, the case is recorded as unvaccinated.
Cases were defined as probably imported if the case-patient was overseas for the full length of the incubation period (7-21 days before onset). Cases among patients who had traveled during this period but that also could have been acquired in the United Kingdom were defined as possibly imported. Sporadic cases who had no travel history but who did have contact with a traveler with a rash illness were defined as import-related.
Clusters were defined on the basis of known contact between cases or if attendance at the same event or the same institution (e.g., hospital, university) occurred during the appropriate period. Other confirmed cases were defined as possibly linked to a cluster if no definite history of contact was obtained but cases were linked geographically and in time. All cases in clusters in which the index case was a probable import or an importrelated case were classified as import-related; This classification was not extended to contacts of possible import cases.
PCR was used to amplify viral genome in oral fluid, whole blood, or urine samples of IgM-positive cases. PCR products were sequenced as previously described [8, 9] , and measles strains detected were classified according to World Health Organization (WHO) nomenclature for wild measles virus genotypes [11] . A phylogenetic tree was constructed by analyzing the 450-nucleotide region of the H gene sequence [12] , using the clustal method (Megalign program; DNASTAR).
Each sporadic case and each cluster was designated a measles event. Genotypes associated with each measles event were analyzed by quarter of onset (taken from the onset date of the sporadic case or for the first case in the cluster). Clusters with more than one genotype identified were subsequently redefined as two events.
RESULTS
An oral fluid sample was received for 19,060 (66%) cases provisionally notified between 1995-2001 (table 1). The annual number of notifications has declined each year, although the number of cases reported was higher in the first 2 quarters than in the second 2 quarters of each year. The proportion of notified cases that was investigated by oral fluid testing was high throughout the period. The proportion found to be IgM positive was low, at !10% in all quarters except for the final quarter of 1997.
A total of 576 cases confirmed IgM positive by oral fluid testing had onset dates in the study period, including 564 cases notified between 1995 and 2001 (table 1), 1 case notified in 2002, and 11 cases for which oral fluid was sent (usually by a hospital microbiologist) directly to ERNVL. One hundred eleven cases were excluded because of a recent history of vaccination, and a further 33 cases were excluded because the initial sample result was thought to be a false positive. This included 5 cases for whom a serum sample tested IgM negative and 29 cases (including 24 in children !18 months of age) for whom the IgM result was low positive (in 19, a second oral fluid sample was IgM and IgG negative; in 5, the result could not be repeated on the initial sample; and in 4, a further sample was not provided). Of the remaining 432 cases, 11 had already been confirmed by earlier serum testing. This left a total of 421 infections first confirmed by testing oral fluid. In addition to cases confirmed by testing oral fluid, a total of 186 infections with onset in the study period were reported from laboratories in England and Wales. At the time of report, 65 were serum IgM positive, 21 had a 4-fold rise in serum measles IgG antibody, 17 had been confirmed by immunofluorescence in clinical samples, and 83 had a high single titer of measles IgG in serum. One hundred cases were subsequently excluded; 50 were found to be IgM negative on serum testing, 6 were IgM negative by oral fluid testing, and 44 that were not investigated further were excluded because of the use of a nonspecific assay at the source laboratory (a single high IgG or immunofluorescence). A further 158 infections were confirmed as serum IgM positive from samples submitted directly to ERNVL, giving a total of 244 cases first confirmed by serology with onset between January 1995 and December 2001.
At the end of follow-up, 285 (43%) of the 665 cases had been confirmed by detection of IgM in serum, 9 (1.4%) by detection of a 4-fold rise in antibody, and 371 (56%) only by IgM detection in у1 oral fluid specimens. One hundred thirtyone (35%) cases that were confirmed only by oral fluid testing were also positive for measles RNA by PCR, including 74 (61%) of 121 of those for which the sample was obtained within 2 weeks of onset.
Trends in the numbers of confirmed cases have not paralleled those among notified cases, and substantial increases in the numbers of confirmed cases have not been reflected in an increase in the total number of notifications (e.g., 4th quarter 1997; table 1). The proportion of cases first tested by using oral fluid as opposed to serum was higher in children than in adults (table 2) .
Of the 665 confirmed cases, 239 (36%) were sporadic and 426 (64%) were associated with 61 clusters. An additional 69 cases in which oral fluid specimens were obtained too late to reliably detect IgM and 49 cases that occurred outside of the study period were epidemiologically linked to these clusters. Including these epidemiologically linked cases, most clusters involved !5 cases (figure 1). On the basis of the distribution of outbreak size during 1995-2001 [5] , the estimated effective reproduction number for measles in England and Wales was between 0.6 and 0.7.
There were 4 clusters that involved 125 cases; all occurred in populations with low vaccine coverage. The largest outbreak occurred between August 1997 and March 1998 in an unvaccinated community that follows the teachings of Rudolph Steiner, an Austrian philosopher with a holistic view of human life; this outbreak involved 142 confirmed cases in 4 different geographic locations and five schools [13] . Two further outbreaks occurred at the end of 1999 and early 2000 in poorly vaccinated religious communities in northwestern England and in London, with 41 and 43 cases, respectively [14] . The final cluster started in late 2001 with 5 cases in a nursery school in inner London, a population where coverage of MMR vaccine has declined in recent years. During 2002, further cases were observed and an outbreak of ∼50 cases involving children in the local community and at neighboring primary schools occurred (see http://www.phls.org.uk/publications/cdr/archive02/ News/news1302.html#measles). In two other large clusters that occurred in greater London (one of 18 and one of 22 cases), many of the case-patients did not have definite contact but were classified as possibly linked because they occurred in geographic and temporal proximity to each other.
Twenty-four clusters were associated with 11 case in an institution: 10 were associated with a hospital, 6 with a university, curred in residential schools for overseas students (with index cases imported from Germany and Russia, respectively), and 2 were in Steiner schools (one cluster involving five schools in 1997 and a further cluster in one school in 1999). The remaining 37 clusters were based mainly either in the community or in a single family. The average annual incidence of confirmed infection was 0.18/100,000 population and the incidence was !1/100,000 in each age group (table 2). The number of infected females slightly exceeded the number of males. Of 665 case-patients, 49 (7.4%) had received a measles-containing vaccine, but none of the confirmed cases had received two or more doses. Analysis of cases by year of birth showed a difference between cases in the large Steiner outbreak compared with those in the general population (figure 2). Excluding the Steiner outbreak, very small numbers of cases were observed in people born between 1979 and 1990-the population targeted for the measles-rubella campaign. Higher numbers of cases occurred in children and adults born between 1971 and 1979, who would have been eligible for single-antigen measles vaccine, but coverage with this vaccine was !70% in the 1970s. Cases were also observed in children born after 1991 who were scheduled to have MMR at between 13 and 15 months of age; a second dose of MMR at preschool age (3.5-4 years) was not introduced until October 1996.
Importations. Fifty-four (23%) of the 239 sporadic cases were associated with importation of infection from overseas. In 5 sporadic cases and 1 cluster, contact with an imported case was implicated (import related) (2 cases from Europe, 1 from the Southeast Asian Region, and 2 in language schools for overseas students from many countries). The single cluster of 4 cases was observed following a case with contact with a US member of a Steiner community who had traveled through several countries.
Genotyping. Genotyping of viral RNA from 234 case-patients (67 sporadic cases and 167 cases in 45 clusters) was performed: 13 distinct genotypes were identified. Measles genotypes are defined on the basis of the H and N genes, and these genes may contain up to 7% variability at the nucleotide level [11] . According to the divergence based on the sequence of the most variable region of the H gene (450 nt), the diver- gence between the UK genotypes shows up to 10%. Even within genotypes, considerable diversity (up to 2%) in strain sequences was observed in sporadic UK cases.
In 32 clusters, viral RNA from 11 case (range, 2-32) was genotyped. The same genotype was detected in all cases in 28 clusters, and different genotypes were detected for 4 clusters. Two of these clusters occurred in universities. In one university cluster, viral RNA from all 4 cases was genotyped, and the final case-patient, who had traveled to Greece and had onset 19 days after the third case, had a different genotype than the other 3 patients. In the other university, viral RNA from all 5 cases was genotyped, and the first 2 case-patients had a different genotype than the final 3 (no history of travel was obtained). Another cluster involved 22 cases in greater London, and genotyping was available for 11 of the case-patients. One of the early casepatients in this cluster had a history of possible importation from Yugoslavia, and this case had the same genotype as 8 other case-patients in the cluster. Two cases that occurred midway through the cluster, with onset dates within 2 weeks of each other, shared a genotype that was distinct from the rest of the cluster; 1 of these case-patients had recently arrived in the United Kingdom, but the source country was not known. In the remaining cluster, the 2 cases occurred 3 weeks apart in a town in northwestern England. The first case had been acquired following contact with an Irish cousin, but the strain identified in the second case had a distinct genotype. These 4 clusters were therefore reclassified into eight events.
Analysis of the genotypes associated with each event showed a wide variety over the surveillance period (table 3) . For each genotype, a period of at least 4 quarters occurred during which no identifications were made. In 20 of the 28 quarters, more than one genotype was identified in association with one or more measles events. Five genotypes (C2, D4, D5, D6, D8) were identified in more than 10 events. The commonest genotype was D6; this genotype was associated with many events in 1996 and 1997 but has not been observed since mid-2000. During 1999-2000, D8 became the commonest type, despite only one identification of this type in 1995-1998. Genotype C2 was not identified after mid-1998, and genotypes D4 and D5 showed no clear trend with time.
The distribution of genotypes in cases with a probable or possible association with importation was similar to those in cases without a recognized link (table 3) . Genotype D4 was the commonest imported strain and was associated mainly with importation from the Indian subcontinent (table 4) . Genotypes C2, D2, D6, and D7 were only linked to importations from Europe; however, C2 was detected in 1 case-patient who had also traveled in sub-Saharan Africa and D2 was detected in a backpacker who had recently arrived in the United Kingdom, but the countries previously visited by this person were not specified. Genotype D8 was associated with importations from the Indian subcontinent across the period but also arose from the Balkans and from Oman during 1998. In a similar manner, genotype D5 was associated with importation from the Far East across the period but from the Indian subcontinent in 2000 and from South America in 2001. Region of origin is less clear for genotype G2, which was associated with a single importation from the Far East in 1997 and with importation from several distinct regions during 2000.
DISCUSSION
The advent of testing oral fluid has transformed the surveillance of measles in England and Wales. Despite a decline in the numbers of notified cases, the proportion of cases tested remains high, and the proportion confirmed is low. With the current epidemiology of measles, clinical notifications of measles do not reflect true trends in the incidence of measles in- fection. The acceptability of noninvasive testing, particularly in children, allows a unique surveillance system that combines the sensitivity of a clinical diagnosis together with the specificity of laboratory investigation.
With a sensitivity of 92% and a specificity of at least 98%, the IgM test on oral fluid is adequate for surveillance, but falsepositive and -negative results may occur [6] . The sensitivity of oral fluid testing in this study is supported by the high proportion of cases in the Steiner outbreak that were confirmed positive for IgM on oral fluid testing [13] . False-positive results are likely to be a greater problem when the incidence of true measles is low, a time when a low predictive value becomes an issue for all diagnostic strategies [10] . By following the confirmatory strategy, a high number of cases tested by oral fluid were also confirmed by serum IgM or RNA detection, suggesting that false-positive results were uncommon. Most falsepositive test results on oral fluid were observed in infants and young children who had low levels of IgM in the initial oral fluid sample. In most cases, a second sample of oral fluid was negative for both IgM and IgG, excluding true infection. Falsepositive IgM results, however, may be a significant issue for oral fluid testing and highlight the need to have a confirmatory strategy.
Given the highly sensitive methods of surveillance in England and Wales, the incidence of confirmed measles remains low. Cases are predominantly observed in unvaccinated children and adults in age groups outside of that targeted in the school campaign in 1994. The success of the campaign is also reflected in the small number of clusters identified in schools. Small numbers of cases have occurred in preschool age groups, and some of these children have a documented history of a single dose of MMR vaccine. Coverage of first-dose MMR was 190% until 1998, and a second dose of MMR was introduced for preschool children in October 1996. The routine second dose will be expected to help prevent such cases in the future, but a recent decline in first-dose MMR coverage to 84% (http:// www.phls.org.uk/publications/cdr/pages/immunisation.html# COVER) will have left a larger proportion of younger cohorts unprotected. So far, however, only one substantial outbreak has been observed in this age group (http://www.phls.org.uk/ publications/cdr/archive02/News/news1302.html#measles).
The low number of cases and the small number of large clusters observed suggests that herd immunity in England and Wales is high. The largest cluster was observed in a community with low vaccine coverage but did not spread to involve the general community, confirming the high level of herd immunity [13] . Other large clusters occurred in inner London, where exposure to people who have traveled to and from endemic countries is likely to be common. The finding of two distinct genotypes in one of these clusters suggests that the observation of large clusters in such settings may be explained by multiple importations rather than by sustained indigenous transmission.
Known importations form a large proportion of sporadic cases were responsible for several clusters. Importation was most commonly recognized from the Indian subcontinent and from Western Europe, probably reflecting the large volume of travel to and from these regions. Many possible importations were recognized from short-term travel in Western Europe, but indigenous transmission could not be excluded. Short-term visitors to the United Kingdom from countries in Western Europe with high incidence of measles are probably common [5] , and illness may only become recognized on return to their (12) 11 (6) 29 (5) 3 (2) 17 (7) 7 (5) 2 (1) 116 (46) NOTE. Data in parentheses represent the number that were imported or import related.
home country. Because of the delay between onset and confirmation, case-patients could not always be contacted to obtain travel histories, and nonresidents of the United Kingdom may have returned to their country of origin. The number of observed infections linked to importation, therefore, is likely to underestimate the true number of cases to a greater extent than for indigenous cases. Despite this underascertainment, the number of cases arising from known importations is consistent with a low effective reproduction number and with elimination of measles in England and Wales [5] . In addition to confirming the diagnosis by IgM detection, oral fluid specimens were useful for detecting measles virus genome by RT-PCR. The source of the viral RNA in oral fluid is not clear, but most likely originates in the upper respiratory tract. A high proportion of IgM-positive oral fluid samples were also positive for measles RNA, particularly if obtained in the first 2 weeks after onset. The potentially important role for oral fluid testing in measles surveillance therefore includes both confirming the diagnosis and characterizing the virus strain on a single noninvasive sample.
Identification of measles strains in the United Kingdom prior to the 1994 campaign [9] confirmed that genotypes D6 and C2 were the predominant strains circulating, and these types were probably shared with the rest of Europe [15] [16] [17] . Between 1995 and 2001, the most common strain observed was genotype D6, and an increase in this genotype was associated with importations from Europe in early 1996. This coincided with an increase in measles incidence in Greece [18] , and D6 strains were reported as causing an outbreak in Germany in 1996 [16] , importations into Luxembourg from Italy, and importations into the United States from several Western European countries [15, 19] . These observations confirm the conclusion that genotype D6 was the predominant genotype in Western Europe. In this survey, evidence of C2 strains being imported from Western Europe was less compelling, but cases of C2 infection were reported in 1996-1997 in Luxembourg and Denmark [15, 16] , coinciding with most C2 identifications in England. The identification of genotype A from Russia and genotype D7 from Western Europe corresponds to the geographic distribution previously described [16, 20] . Genotype D4 was associated with several importations from the Indian subcontinent [19] , and since travel between this region and the United Kingdom is common, it perhaps explains the frequent identification of this strain. The identification of genotype D8 in 1999-2000 is more interesting because importations from south Asia, the Middle East, and the Balkans were associated with this genotype at that time. The same type was identified in Ethiopia in 1998-1999 [21] , and some importations may reflect the increase in measles observed during 1998 in both the African and Eastern Mediterranean regions [18] . Although genotyping has been useful in describing measles diversity, we have not been able to attribute all of the less common genotypes to importation from specific regions. Genotype D2, previously described in South Africa [22] , and genotypes G2 and D5, previously linked to the Far East [19, 20, 23] , were associated with possible importations from other regions. A lack of consistent findings over time will probably reflect the reimportation of strains from endemic areas into those populations that had interrupted measles transmission, such the Americas. The wide diversity of genotypes, the absence of each genotype for prolonged periods of time, and the finding of a similar distribution of genotypes in indigenous and imported cases, however, supports the belief that most cases in England and Wales arise from importation of infection.
In addition to the pattern of importation and the high proportion of sporadic cases with distinct genotypes, the small cluster size observed is consistent with a low effective reproduction number and compatible with measles elimination [5, 24] . It has been suggested that surveillance in the United Kingdom may underestimate cluster size because of failure to identify links between cases [24] . The data presented here indicate that we have had a low threshold for attributing links between cases on the basis of proximity in time and place. The observation of two distinct genotypes in four clusters suggests that we may be overestimating outbreak size. The absence of links between sporadic cases is also supported by the diversity of measles genotypes observed in each quarter. Even within genotypes, considerable diversity was observed among strains detected in sporadic cases, suggesting that direct transmission between such cases was not occurring. When travel to and from measles-endemic countries (such as those in Western Europe and the Indian subcontinent) is common, as it is in the United Kingdom, then multiple importations will occur. With a sensitive surveillance system based on noninvasive testing, such as that described here, it is not surprising that large numbers of sporadic cases will be commonly observed.
We believe that surveillance in England and Wales has clearly demonstrated the absence of sustained indigenous transmission and therefore the elimination of measles. Interruption of transmission has been achieved by high routine vaccination coverage for MMR, a successful campaign using measles-rubella vaccine in older children [4, 25] , and the introduction of a second dose of MMR. The ability to maintain this level of measles control, in the face of frequent importations from neighboring countries, will require continued high coverage with two doses of measles-containing vaccines. The recent decline in first-dose MMR coverage, which is associated with unfounded concerns about vaccine safety [26] , illustrates the difficulty with sustaining a successful program in the absence of natural disease. The continued threat of measles becoming reestablished in the United Kingdom can only be avoided by a global effort to control measles. The acceptance of a measles elimination target in several WHO regions [14, 27] , and most importantly in Europe [28] , is therefore to be welcomed.
